- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2052-3211
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Drug pricing and reimbursement decision making systems in Mongolia ; volume:10 ; number:1 ; day:27 ; month:2 ; year:2017 ; pages:1-11 ; date:12.2017
Journal of pharmaceutical policy and practice ; 10, Heft 1 (27.2.2017), 1-11, 12.2017
- Schlagwort
-
Arzneimittelentwicklung
Arzneimitteldesign
- Urheber
-
Dorj, Gereltuya
- Beteiligte Personen und Organisationen
-
Sunderland, Bruce
Sanjjav, Tsetsegmaa
Dorj, Gantuya
Gendenragchaa, Byambatsogt
SpringerLink (Online service)
- DOI
-
10.1186/s40545-017-0098-6
- URN
-
urn:nbn:de:1111-201703221106
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dorj, Gereltuya
- Sunderland, Bruce
- Sanjjav, Tsetsegmaa
- Dorj, Gantuya
- Gendenragchaa, Byambatsogt
- SpringerLink (Online service)
Ähnliche Objekte (12)
Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance
On the welfare analysis of external reference pricing and reimbursement policy
Pricing and reimbursement of orphan drugs: the need for more transparency
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Integration of manufacturing and pricing for downward substitution products decision-making
Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey
Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement
The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs
Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries
Strategie decision making : nothing else than mere decision making?
Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance
On the welfare analysis of external reference pricing and reimbursement policy
Pricing and reimbursement of orphan drugs: the need for more transparency
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Integration of manufacturing and pricing for downward substitution products decision-making
Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey
Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement
The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs
Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries
Strategie decision making : nothing else than mere decision making?
Decision-making criteria for medicine reimbursement in Slovenia: an expert panel discussion
Pricing and Reimbursement of Prescription Drugs in German Social Health Insurance
On the welfare analysis of external reference pricing and reimbursement policy
Pricing and reimbursement of orphan drugs: the need for more transparency
Approval, reimbursement and pricing of high-cost cancer medicines in Australia
Integration of manufacturing and pricing for downward substitution products decision-making
Engaging the Canadian public on reimbursement decision-making for drugs for rare diseases: a national online survey
Cost-analysis of XELOX and FOLFOX4 for treatment of colorectal cancer to assist decision-making on reimbursement
The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs
Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries